Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0004031,
umls-concept:C0010592,
umls-concept:C0011777,
umls-concept:C0017262,
umls-concept:C0026336,
umls-concept:C0079189,
umls-concept:C0185117,
umls-concept:C0205369,
umls-concept:C0220781,
umls-concept:C0591833,
umls-concept:C1709059,
umls-concept:C1883254,
umls-concept:C2911684
|
pubmed:issue |
11
|
pubmed:dateCreated |
1997-3-11
|
pubmed:abstractText |
We previously demonstrated that, in C57B1/6 mice, cyclosporin A enhanced and dexamethasone inhibited the Aspergillus fumigatus-induced pulmonary eosinophilia and total IgE levels. To evaluate whether these effects were related to the modulation of T-lymphocyte recruitment and activation and cytokine expression, we performed immunohistochemical staining for T-cell surface marker CD3 and CD4, cell activation marker CD25, and cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-4 (IL-4) and interleukin-5 (IL-5) on lung tissue sections from mice exposed to Aspergillus fumigatus and treated or not with dexamethasone or cyclosporin A. Dexamethasone significantly inhibited Aspergillus fumigatus-induced increased number of activated T cells and cytokine-expressing cells in parallel with a decrease in pulmonary eosinophils. In contrast, cyclosporin A did not decrease these immunological events but enhanced the lung eosinophil recruitment. Moreover, dexamethasone prevented the production of immunoglobulins against 76 and 36 kD antigen proteins and cyclosporin A against 76 and 18 kD antigen proteins. These results indicate that dexamethasone down-regulates and cyclosporin A up-regulates lung eosinophil recruitment and total IgE production, probably via the modulation of T-lymphocyte activation and GM-CSF, IL-4 and IL-5 expression. Both drugs inhibit Aspergillus fumigatus-specific antibody synthesis, but their suppressive actions are selective to different antigenic components.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-2972
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
951-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8957199-Animals,
pubmed-meshheading:8957199-Antibodies, Fungal,
pubmed-meshheading:8957199-Antibody Formation,
pubmed-meshheading:8957199-Antigens, Surface,
pubmed-meshheading:8957199-Aspergillosis, Allergic Bronchopulmonary,
pubmed-meshheading:8957199-Blotting, Western,
pubmed-meshheading:8957199-Cytokines,
pubmed-meshheading:8957199-Dexamethasone,
pubmed-meshheading:8957199-Disease Models, Animal,
pubmed-meshheading:8957199-Female,
pubmed-meshheading:8957199-Mice,
pubmed-meshheading:8957199-Mice, Inbred C57BL
|
pubmed:year |
1996
|
pubmed:articleTitle |
Dexamethasone and cyclosporin A modulation of cytokine expression and specific antibody synthesis in an allergic bronchopulmonary aspergillosis murine model.
|
pubmed:affiliation |
Unité de Recherche, Hôpital Laval, Ste-Foy, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|